Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Birkholz · SciRah

Researcher profile · Semantic Scholar

K. Birkholz

Share profile

K. Birkholz — researcher profile on SciRah

h-index: 10
Works: 27
Citations: 462

Most-cited papers

Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
K. Birkholz, Michael Schwenkert, C. Kellner, S. Gross +5 more
2010Blood147 citations
Semantic Scholar
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
K. Birkholz, A. Hombach, Christian Krug, S. Reuter +6 more
2009Gene Therapy114 citations Open access
Semantic Scholar
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone
Christian Krug, K. Birkholz, A. Paulus, Michael Schwenkert +9 more
2015Cancer Immunology and Immunotherapy53 citations Open access
Semantic Scholar
Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study
Peyman Hadji, Anette Kauka, M. Ziller, K. Birkholz +3 more
2014Osteoporosis International29 citations
Semantic Scholar
A fast and robust method to clone and functionally validate T-cell receptors.
K. Birkholz, C. Hofmann, S. Hoyer, B. Schulz +5 more
2009JIM - Journal of Immunological Methods28 citations
Semantic Scholar
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells
Michael Schwenkert, K. Birkholz, Michael Schwemmlein, C. Kellner +9 more
2008Melanoma research22 citations Open access
Semantic Scholar
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff +15 more
2014Cancer Microenvironment14 citations Open access
Semantic Scholar
Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study
P. Hadji, A. Kauka, M. Ziller, K. Birkholz +3 more
2014Breast Cancer Research and Treatment13 citations
Semantic Scholar
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
U. Tunn, A. Stenzl, W. Schultze-Seemann, A. Strauß +9 more
2012The Canadian journal of urology11 citations
Semantic Scholar
A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC).
A. Reichle, M. Vogelhuber, S. Feyerabend, T. Suedhoff +8 more
2011Journal of Clinical Oncology10 citations
Semantic Scholar
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season
R. Mösges, Nils Y. Breitrück, S. Allekotte, K. Shah-Hosseini +9 more
2019The World Allergy Organization Journal6 citations Open access
Semantic Scholar
The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
P. Hadji, M. Ziller, T. Maurer, M. Autenrieth +8 more
2012Journal of Bone Oncology4 citations Open access
Semantic Scholar
P2-19-03: Influence of Zoledronic Acid on BMD in Premenopausal Women with Breast Cancer and Neoadjuvant or Adjuvant Chemotherapy and/or Endocrine Treatment – The ProBone Studies.
P. Hadji, A. Kauka, T. Bauer, M. Kalder +5 more
20114 citations
Semantic Scholar
Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting
P. Zieglmayer, R. Mösges, S. Allekotte, Sandra Weissenbaeck +6 more
2020Allergo Journal International2 citations Open access
Semantic Scholar
Dendritic cell vaccination and other strategies to tip the balance of the immune system
N. Schaft, K. Birkholz, C. Hofmann, M. Schmid +2 more
2008Cancer Immunology and Immunotherapy2 citations Open access
Semantic Scholar
Dendritic cell vaccination and other strategies to tip the balance of the immune system
N. Schaft, K. Birkholz, C. Hofmann, M. Schmid +2 more
2008Cancer Immunology and Immunotherapy2 citations Open access
Semantic Scholar
The ZOTECT study: Effect of intravenous zoledronic acid on bone metabolism in patients with metastatic bone disease in prostate cancer (PC) and breast cancer (BC).
Peyman Hadji, M. Ziller, Tobias Maurer, M. Muth +4 more
2011Journal of Clinical Oncology1 citations
Semantic Scholar
Short-Course Allergen-Specific Immunotherapy with Modified Grass/Tree Allergoids Using a Microcrystalline Tyrosine (MCT®) and Monophosphoryl Lipid A (MPL) Adjuvant System Decreases Specific Immunoglobulin E Levels
D. Stollewerk, Marion Niebecker, E. Fuchs, Laura England +7 more
2022European Journal of Rhinology and Allergy0 citations Open access
Semantic Scholar
Effects of zoledronic acid on hormone levels in premenopausal women with breast cancer receiving neoadjuvant or adjuvant chemotherapy and endocrine therapy: Probone II Study
P. Hadji, Anette Kauka, T. Bauer, M. Ziller +4 more
20130 citations
Semantic Scholar
Redirecting and Modulating Rationalizations of Tumor-Immanent Normative Functions in Castration-Resistant Prostate Cancer
M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff +14 more
20130 citations
Semantic Scholar
Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer: the ZOTECT Study
P. Hadji, M. Ziller, T. Maurer, M. Autenrieth +8 more
20130 citations
Semantic Scholar
Effect of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for breast cancer: the ProBONE II Study
P. Hadji, Anette Kauka, T. Bauer, K. Birkholz +3 more
20130 citations
Semantic Scholar
NFĸB-SIGNALWEG-MANIPULIERTE DENDRITISCHE ZELLEN
K. Birkholz, J. Dörrie, I. Pfeiffer, N. Schaft +2 more
20110 citations
Semantic Scholar
DEC-205 targeting of dendritic cells: a challenging approach of antigen loading
K. Birkholz, I. Pfeiffer, Michael Schwenkert, C. Kellner +6 more
20110 citations
Semantic Scholar
manipulated dendritic cells in its path signal transmission NFkB
K. Birkholz, J. Dörrie, N. Schaft, G. Schuler +2 more
20110 citations
Semantic Scholar
CELLULES DENDRITIQUES À VOIE DE SIGNALISATION NFkB MANIPULÉE
K. Birkholz, J. Dörrie, N. Schaft, G. Schuler +2 more
20110 citations
Semantic Scholar
Strategies for immune intervention; from bench to bedside
J. Dörrie, K. Birkholz, N. Schaft
2007Cancer Immunology and Immunotherapy0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Schaft×12
Invite
N. Schaft — researcher profile on SciRah
J. Dörrie×12
Invite
J. Dörrie — researcher profile on SciRah
M. Baier×8
Invite
M. Baier — researcher profile on SciRah
M. Muth×8
Invite
M. Muth — researcher profile on SciRah

×7

Invite

A. Ruebel — researcher profile on SciRah

Invite

M. Ziller — researcher profile on SciRah

Invite

P. Hadji — researcher profile on SciRah

Invite

G. Schuler — researcher profile on SciRah

Michael Schwenkert×4

Invite

Michael Schwenkert — researcher profile on SciRah

Invite

G. Fey — researcher profile on SciRah

B. Schuler-Thurner×4

Invite

B. Schuler-Thurner — researcher profile on SciRah

Invite

M. Schulze — researcher profile on SciRah